• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

12 - [(5 - 碘 - 4 - 叠氮基 - 2 - 羟基苯甲酰基)氨基]十二烷酸:胆固醇酯酶和酰基辅酶A:胆固醇O - 酰基转移酶的生物识别作用

12-[(5-iodo-4-azido-2-hydroxybenzoyl)amino]dodecanoic acid: biological recognition by cholesterol esterase and acyl-CoA:cholesterol O-acyltransferase.

作者信息

Kinnunen P M, Klopf F H, Bastiani C A, Gelfman C M, Lange L G

机构信息

Department of Medicine, Jewish Hospital, St. Louis, Missouri 63110.

出版信息

Biochemistry. 1990 Feb 13;29(6):1648-54. doi: 10.1021/bi00458a042.

DOI:10.1021/bi00458a042
PMID:2334723
Abstract

Potential probes of protein cholesterol and fatty acid binding sites, namely, 12-[(5-iodo-4-azido-2-hydroxybenzoyl)amino]dodecanoate (IFA) and its coenzyme A (IFA:CoA) and cholesteryl (IFA:CEA) esters, were synthesized. These radioactive, photoreactive lipid analogues were recognized as substrates and inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) and cholesterol esterase, neutral lipid binding enzymes which are key elements in the regulation of cellular cholesterol metabolism. In the dark, IFA reversibly inhibited cholesteryl [14C]oleate hydrolysis by purified bovine pancreatic cholesterol esterase with an apparent Ki of 150 microM. Cholesterol esterase inhibition by IFA became irreversible after photolysis with UV light and oleic acid (1 mM) provided 50% protection against inactivation. Incubation of homogeneous bovine pancreatic cholesterol esterase with IFA:CEA resulted in its hydrolysis to IFA and cholesterol, indicating recognition of IFA:CEA as a substrate by cholesterol esterase. The coenzyme A ester, IFA:CoA, was a reversible inhibitor of microsomal ACAT activity under dark conditions (apparent Ki = 20 microM), and photolysis resulted in irreversible inhibition of enzyme activity with 87% efficiency. IFA:CoA was also recognized as a substrate by both liver and aortic microsomal ACATs, with resultant synthesis of 125IFA:CEA. IFA and its derivatives, IFA:CEA and IFA:CoA, are thus inhibitors and substrates for cholesterol esterase and ACAT. Biological recognition of these photoaffinity lipid analogues will facilitate the identification and structural analysis of hitherto uncharacterized protein lipid binding sites.

摘要

合成了蛋白质胆固醇和脂肪酸结合位点的潜在探针,即12-[(5-碘-4-叠氮基-2-羟基苯甲酰基)氨基]十二烷酸酯(IFA)及其辅酶A(IFA:CoA)和胆固醇酯(IFA:CEA)。这些放射性、光反应性脂质类似物被认为是酰基辅酶A:胆固醇O-酰基转移酶(ACAT)和胆固醇酯酶的底物和抑制剂,这两种中性脂质结合酶是细胞胆固醇代谢调节的关键要素。在黑暗中,IFA可逆地抑制纯化的牛胰腺胆固醇酯酶对胆固醇[14C]油酸酯的水解,表观Ki为150微摩尔。用紫外光光解后,IFA对胆固醇酯酶的抑制作用变得不可逆,1毫摩尔油酸提供了50%的失活保护。将均质的牛胰腺胆固醇酯酶与IFA:CEA一起孵育导致其水解为IFA和胆固醇,表明胆固醇酯酶将IFA:CEA识别为底物。辅酶A酯IFA:CoA在黑暗条件下是微粒体ACAT活性的可逆抑制剂(表观Ki = 20微摩尔),光解导致酶活性不可逆抑制,效率为87%。IFA:CoA也被肝脏和主动脉微粒体ACAT识别为底物,从而合成了125IFA:CEA。因此,IFA及其衍生物IFA:CEA和IFA:CoA是胆固醇酯酶和ACAT的抑制剂和底物。这些光亲和性脂质类似物的生物学识别将有助于鉴定和结构分析迄今未表征的蛋白质脂质结合位点。

相似文献

1
12-[(5-iodo-4-azido-2-hydroxybenzoyl)amino]dodecanoic acid: biological recognition by cholesterol esterase and acyl-CoA:cholesterol O-acyltransferase.12 - [(5 - 碘 - 4 - 叠氮基 - 2 - 羟基苯甲酰基)氨基]十二烷酸:胆固醇酯酶和酰基辅酶A:胆固醇O - 酰基转移酶的生物识别作用
Biochemistry. 1990 Feb 13;29(6):1648-54. doi: 10.1021/bi00458a042.
2
Regulation of hepatic cholesterol ester hydrolase and acyl-coenzyme A:cholesterol acyltransferase in the rat.大鼠肝脏胆固醇酯水解酶和酰基辅酶A:胆固醇酰基转移酶的调节
J Lipid Res. 1989 Nov;30(11):1681-90.
3
Studies on the activity of acyl-CoA:cholesterol O-acyltransferase and acid cholesterol ester synthetase in rat aortas.大鼠主动脉中酰基辅酶A:胆固醇O-酰基转移酶和酸性胆固醇酯合成酶活性的研究。
Biochim Biophys Acta. 1981 Jun 23;664(3):475-86. doi: 10.1016/0005-2760(81)90126-0.
4
Chemical modification of acyl-CoA:cholesterol O-acyltransferase. 2. Identification of a coenzyme A regulatory site by p-mercuribenzoate modification.酰基辅酶A:胆固醇O-酰基转移酶的化学修饰。2. 通过对氯汞苯甲酸修饰鉴定辅酶A调节位点。
Biochemistry. 1988 Sep 20;27(19):7351-6. doi: 10.1021/bi00419a026.
5
Microsomal long chain fatty acyl-CoA transacylation: differential effect of sterol carrier protein-2.微粒体长链脂肪酰辅酶A转酰基作用:固醇载体蛋白-2的差异效应
Biochim Biophys Acta. 1999 Aug 18;1439(3):371-83. doi: 10.1016/s1388-1981(99)00109-2.
6
The arterial acyl-CoA:cholesterol acyltransferase and cholesterol ester hydrolase activities.动脉酰基辅酶A:胆固醇酰基转移酶和胆固醇酯水解酶活性。
Atherosclerosis. 1975 Sep-Oct;22(2):287-91. doi: 10.1016/0021-9150(75)90009-x.
7
The effect of bile salts on the formation and hydrolysis of cholesterol esters by rat liver enzymes.胆汁盐对大鼠肝脏酶形成和水解胆固醇酯的影响。
Biochim Biophys Acta. 1977 Apr 26;487(1):137-44. doi: 10.1016/0005-2760(77)90050-9.
8
Incorporation of lipoxygenase products into cholesteryl esters by acyl-CoA:cholesterol acyltransferase in cholesterol-rich macrophages.在富含胆固醇的巨噬细胞中,脂氧合酶产物通过酰基辅酶A:胆固醇酰基转移酶掺入胆固醇酯中。
Biochem J. 1988 Dec 15;256(3):807-14. doi: 10.1042/bj2560807.
9
Chemical modification of acyl-CoA:cholesterol O-acyltransferase. 1. Identification of acyl-CoA:cholesterol O-acyltransferase subtypes by differential diethyl pyrocarbonate sensitivity.酰基辅酶A:胆固醇O-酰基转移酶的化学修饰。1. 通过焦碳酸二乙酯敏感性差异鉴定酰基辅酶A:胆固醇O-酰基转移酶亚型。
Biochemistry. 1988 Sep 20;27(19):7344-50. doi: 10.1021/bi00419a025.
10
Human acyl-CoA:cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis.人酰基辅酶A:胆固醇酰基转移酶(ACAT)及其作为抗动脉粥样硬化药物干预靶点的潜力。
Acta Biochim Biophys Sin (Shanghai). 2006 Mar;38(3):151-6. doi: 10.1111/j.1745-7270.2006.00154.x.

引用本文的文献

1
Photoreactive fatty acid analogues that bind to the rat liver fatty-acid binding protein: 11-(5'-azido-salicylamido)-undecanoic acid derivatives.与大鼠肝脏脂肪酸结合蛋白结合的光反应性脂肪酸类似物:11-(5'-叠氮基水杨酰胺基)-十一烷酸衍生物。
Mol Cell Biochem. 1993 Mar 10;120(1):15-23. doi: 10.1007/BF00925980.